Overview of 2009 Hong Kong Cancer Statistics

Similar documents
Overview of 2010 Hong Kong Cancer Statistics

Overview of 2013 Hong Kong Cancer Statistics

Overview of Hong Kong Cancer Statistics of 2015

National Cancer Statistics in Korea, 2014

Information Services Division NHS National Services Scotland

Cancer survival in Hong Kong SAR, China,

Information Services Division NHS National Services Scotland

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer

Cancer in Ireland : Annual Report of the National Cancer Registry

Cancer survival in Seoul, Republic of Korea,

Cancer in the Northern Territory :

Cancer in Estonia 2014

Cancer survival in Shanghai, China,

Cancer survival in Busan, Republic of Korea,

APPENDIX ONE: ICD CODES

Cancer in Ireland : Annual Report of the National Cancer Registry

Cancer prevalence. Chapter 7

ALL CANCER (EXCLUDING NMSC)

Epidemiology in Texas 2006 Annual Report. Cancer

Information Services Division NHS National Services Scotland

ALL CANCER (EXCLUDING NMSC)

Cancer in Ireland with estimates for

Chapter 1 MAGNITUDE AND LEADING SITES OF CANCER

Prediction of Cancer Incidence and Mortality in Korea, 2018

Background. Background. AYA Overview. Epidemiology of AYA Cancers in Texas

Current cancer incidence and trends in Yaounde, Cameroon

Annual report on status of cancer in China, 2010

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996

Cancer in Central and South America BOLIVIA

Burden of Cancer in California

CANCER IN IRELAND with estimates for : ANNUAL REPORT OF THE NATIONAL CANCER REGISTRY

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

Cancer in Utah: An Overview of Cancer Incidence and Mortality from

Republican Research and Practical Center for Radiation Medicine and Human Ecology. Ilya Veyalkin Head of Laboratory of Epidemiology Gomel, Belarus

Prediction of Cancer Incidence and Mortality in Korea, 2013

ANNUAL CANCER REGISTRY REPORT-2005

CANCER FACTS & FIGURES For African Americans

Survival in Teenagers and Young. Adults with Cancer in the UK

Cancer survival in Chennai (Madras), India,

Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group

Outcomes Report: Accountability Measures and Quality Improvements

Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group

Diagnosing cancer in an emergency: Patterns of emergency presentation of cancer in Ireland

Cancer Association of South Africa (CANSA) Fact Sheet on the Top Ten Cancers per Population Group

Physician On-line Staging Application. Darlene Dale Head, PMH Cancer Registry

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1995

Cancer in Rural Illinois, Incidence, Mortality, Staging, and Access to Care. April 2014

CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster

Trends in Cancer Survival in Scotland

IJC International Journal of Cancer

Cancer Survival in Wales, Goroesi Cancr yng Nghymru,

*

Cancer in New Brunswick

Cancer Facts & Figures for African Americans

Cancer incidence in the Republic of Mauritius- 5 Years Review 1997 to 2001

What is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*

NICaN workshop: Colorectal Cancer Follow-up

Human Papillomavirus and Related Diseases Report NEW ZEALAND

Supplementary Online Content

Dread Disease Insurance towards local experience

DATA UPDATE: CANCER INCIDENCE IN DAKOTA AND WASHINGTON COUNTIES

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Trends and disparities in cancer in Aotearoa/ NZ

Cancer Incidence and Mortality: District Cancer Registry, Trivandrum, South India

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2009

Cancer in the Arabian Gulf Kingdom of Bahrain ( ) Fayek A Alhilli, PhD (Path)* Nagalla S Das, MD*

The Greater Bay Area Cancer Registry Annual Report: Incidence and Mortality Review,

DATA UPDATE: CANCER INCIDENCE IN DAKOTA AND WASHINGTON COUNTIES

Cancer in Kuwait: Magnitude of The Problem

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

A research briefing paper by Macmillan Cancer Support

Cancer in New Mexico 2014

NIH Public Access Author Manuscript Cancer. Author manuscript; available in PMC 2006 December 17.

Chapter 2 Geographical patterns in cancer in the UK and Ireland

Chapter II: Overview

Human Papillomavirus and Related Diseases Report BOTSWANA

Human Papillomavirus and Related Diseases Report SWAZILAND

Trends in Cancer Survival in NSW 1980 to 1996

Human Papillomavirus and Related Diseases Report EGYPT

Cancer Incidence and Mortality in the Kingdom of Bahrain Statistics and Trends

Analyses on Cancer Incidence and Mortality in Huai an Area, China, 2010

Cancer Trends in Northern Ireland: D. Fitzpatrick, A. Gavin, D. Donnelly

Suggested Citation: Copyright Information:

Cancer Incidences in Rural Delhi

HOSPITAL-BASED CANCER REGISTRY ANNUAL REPORT 2011

Cancer Association of South Africa (CANSA)

Cancer in California:

2018 Texas Cancer Registry Annual Report

Annual Report to the Nation on the Status of Cancer, , Featuring Survival Questions and Answers

Cancer in New Mexico 2017

CANCER IN NSW ABORIGINAL PEOPLES. Incidence, mortality and survival September 2012

Cancer survival in Bhopal, India,

Unequal Impact: Māori and Non-Māori Cancer Statistics

Hazelinks - Cancer incidence analysis (First data extraction)

Human Papillomavirus and Related Diseases Report LESOTHO

Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials

The Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012

Human Papillomavirus and Related Diseases Report CHINA

An epidemiological analysis of cancer patients admitted to hospitals in Chennai, Tamil Nadu

Transcription:

Overview of 2009 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since 1963 been providing population-based cancer data for epidemiological research and healthcare services planning in Hong Kong. With the support of healthcare professionals and medical institutions, we collect high quality hospital and laboratory cancer data from both private and public sectors. Further details of the Registry and related cancer statistics are available on our web (http://www.ha.org.hk/cancereg). Major findings in 2009 25,977 new were diagnosed with malignancy (+1,342 new or increased by 5.4% compared to previous year). Most of the increase was attributed to the growing number of increase in colorectal and non-melanoma skin cancers in both genders, prostate and pancreatic cancers in men, breast and cervical cancers in women. Number of colorectal cancer is getting closer to lung cancer although it is still no. 2 leading cancer. Number of female breast cancer increased by 12.5% to 2,945 in 2009 compared to previous year. Data are presented for the first time about the of in-situ breast cancer in females. Altogether there were a further 443 reported during 2009. The reporting of in-situ of breast cancer will be of interest in monitoring the number of pre-malignant abnormalities. Number of cervical cancer has once dropped by nearly 20% since the setting up of government s screening programme in 2004 but it rose dramatically (+95 or 26%) during 2009. However, one should keep in mind that the figures are subject to random fluctuations from year to year. Experience tells us that a more reliable comment of the trend of can only be made after observing over a longer period, normally 5 years more. 12,839 died from cancer in 2009 (+383 or 3.1%). Cancer was a leading cause of death in Hong Kong, accounting for 31.2% of all. Hong Kong Cancer Registry, Hospital Authority. Last updated: Nov 2017 1

Leading cancer types (both genders combined) No. in 2009 No. in 1999 (rank) 1 Lung cancer 4, 365 3,707 (1) 2 Colorectal cancer 4,335 3,024 (2) 3 Breast cancer 2,962 1,796 (3) 4 Liver cancer 1,832 1,572 (4) 5 Prostate cancer 1,484 597 (9) All cancers 25,977 20,525 Leading cancer (both genders combined) No. in 2009 No. in 1999 (rank) 1 Lung cancer 3,692 3,168 (1) 2 Colorectal cancer 1,752 1,329 (3) 3 Liver cancer 1,488 1,420 (2) 4 Stomach cancer 656 699 (4) 5 Breast cancer 555 399 (5) All cancers 12,839 10,977 Appendix 1 displays the ten most common cancers and cancer killers by gender in 2009. Cancer and gender More men were diagnosed with cancer (13,681) than women (12,296) in the ratio of 1.11 to 1. More men died from cancer (7,682) than women (5,157) in the ratio of 1.49 to 1. Cancer and age Cancer is primarily a disease of older people: Over 60% of cancers occurred in people over the age of 60. Fewer than 1% of cancers occurred before the age of 20. Median ages at diagnosis were 69 years in men and 61 years in women. Three-fourth of cancer occurred in persons aged 60 or older. Median ages at death due to cancer were 72 years in men and 74 years in women. Hong Kong Cancer Registry, Hospital Authority. Last updated: Nov 2017 2

Appendix 2 displays the relative of the five most common cancers by gender and age Group in 2009. Risk of developing of and dying from cancer before age 75 A person's risk of developing or dying from cancer is dependent on age: One in 4 men and 1 in 5 women will develop some form of cancer before the age of 75. One in 8 men and 1 in 14 women will die from cancer before the age of 75. Any feedback or queries are welcomed. Please send us an email to cancereg@ha.org.hk. Hong Kong Cancer Registry, Hospital Authority. Last updated: Nov 2017 3

Appendix 1: Leading Cancer s in 2009 10 Most Common Cancers 10 Major Causes of Cancer Deaths 1 Lung 2,848 20.8% 86.7 1 Lung 2,465 32.1% 75.0 2 Colorectum 2,405 17.6% 73.2 2 Liver 1,072 14.0% 32.6 3 Prostate 1,484 10.8% 45.2 3 Colorectum 999 13.0% 30.4 4 Liver 1,385 10.1% 42.2 4 Stomach 414 5.4% 12.6 5 Stomach 682 5.0% 20.8 5 Prostate 306 4.0% 9.3 6 Nasopharynx 678 5.0% 20.6 6 Nasopharynx 281 3.7% 8.6 7 Non-melanoma skin 412 3.0% 12.5 7 Oesaphagus 269 3.5% 8.2 8 Non-Hodgkin lymphoma 401 2.9% 12.2 8 Pancreas 249 3.2% 7.6 9 Oesophagus 345 2.5% 10.5 9 Non-Hodgkin lymphoma 186 2.4% 5.7 10 Lip, oral cavity and pharynx 333 2.4% 10.1 10 Leukaemia 144 1.9% 4.4 except nasopharynx All sites 13,681 100.0% 416.5 All sites 7,682 100.0% 233.9 1 Breast 2,945 24.0% 79.9 1 Lung 1,227 23.8% 33.3 2 Colorectum 1,930 15.7% 52.3 2 Colorectum 753 14.6% 20.4 3 Lung 1,517 12.3% 41.1 3 Breast 555 10.8% 15.0 4 Corpus uteri 667 5.4% 18.1 4 Liver 416 8.1% 11.3 5 Thyroid 507 4.1% 13.7 5 Stomach 242 4.7% 6.6 6 Ovary etc. 460 3.7% 12.5 6 Pancreas 200 3.9% 5.4 7 Cervix 453 3.7% 12.3 7 Non-Hodgkin lymphoma 142 2.8% 3.9 8 Liver 447 3.6% 12.1 7 Ovary etc. 142 2.8% 3.9 9 Non-melanoma skin 399 3.2% 10.8 9 Cervix 128 2.5% 3.5 10 Stomach 396 3.2% 10.7 10 Leukaemia 126 2.4% 3.4 All sites 12,296 100.0% 333.4 All sites 5,157 100.0% 139.8 Both Sexes Both Sexes 1 Lung 4,365 16.8% 62.6 1 Lung 3,692 28.8% 52.9 2 Colorectum 4,335 16.7% 62.2 2 Colorectum 1,752 13.6% 25.1 3 Breast 2,962 11.4% 42.5 3 Liver 1,488 11.6% 21.3 4 Liver 1,832 7.1% 26.3 4 Stomach 656 5.1% 9.4 5 Prostate 1,484 5.7% 45.2 5 Breast 555 4.3% 8.0 6 Stomach 1,078 4.1% 15.5 6 Pancreas 449 3.5% 6.4 7 Nasopharynx 914 3.5% 13.1 7 Non-Hodgkin lymphoma 359 2.8% 5.1 8 Non-melanoma skin 811 3.1% 11.6 8 Oesophagus 328 2.6% 4.7 9 Non-Hodgkin lymphoma 730 2.8% 10.5 9 Nasopharynx 328 2.6% 4.7 10 Corpus uteri 667 2.6% 18.1 10 Prostate 306 2.4% 9.3 All sites 25,977 100.0% 372.5 All sites 13,076 100.0% 184.1 * All rates are expressed per 100,000. Rates for gender-specific sites are per 100,000 male or female population. Statistics on the number of are provided by the Census and Statistics Department and Department of Health of HKSAR. Hong Kong Cancer Registry, Hospital Authority. Last updated: Nov 2017 4

Appendix 2: Frequency of the Five Most Common Cancers by Gender and Age Group in 2009 Age 0-19* Age 0-19* of sites of sites Leukaemia 31 28.4% Leukaemia 17 21.3% Brain and spinal tumors 24 22.0% Carcinomas and epithelial neoplasms 12 15.0% Lymphoma 14 12.8% Lymphoma 11 13.8% Germ-cell and gonadal tumors 11 10.1% Germ-cell and gonadal tumors 11 13.8% Carcinomas and epithelial neoplasms 8 7.3% Brian and spinal tumors 10 12.5% All sites 109 100.0% All sites 80 100.0% Age 20-44 Age 20-44 of sites of sites Nasopharynx 168 20.8% Breast 596 34.6% Colorectum 92 11.4% Thyroid 202 11.7% Liver 87 10.8% Ovary etc. 134 7.8% Lung 57 7.1% Cervix 132 7.7% Non-Hogkin lymphoma 48 5.9% Corpus uteri 93 5.4% All sites 808 100.0% All sites 1,725 100.0% Age 45-64 Age 45-64 of sites of sites Lung 839 18.0% Breast 1,676 33.8% Colorectum 779 16.7% Colorectum 591 11.9% Liver 695 14.9% Lung 470 9.5% Nasopharynx 390 8.4% Corpus uteri 434 8.8% Prostate 279 6.0% Thyroid 242 4.9% All sites 4,657 100.0% All sites 4,959 100.0% Age 65-74 Age 65-74 of sites of sites Lung 819 22.4% Colorectum 405 21.7% Colorectum 686 18.7% Lung 306 16.4% Prostate 594 16.2% Breast 304 16.3% Liver 323 8.8% Liver 104 5.6% Stomach 175 4.8% Corpus uteri 74 4.0% All sites 3,664 100.0% All sites 1,870 100.0% Age 75 and Over Age 75 and Over of sites of sites Lung 1,133 25.5% Colorectum 848 23.2% Colorectum 848 19.1% Lung 682 18.6% Prostate 610 13.7% Breast 369 10.1% Liver 278 6.3% Non-melanoma skin 219 6.0% Stomach 278 6.3% Liver 190 5.2% All sites 4,442 100.0% All sites 3,662 100.0% Note: Cases with unknown age are not included in the above table. * The classification of cancers in children and adolescents (0-19 years) is based on the morphology according to the "International Classification for Childhood Cancer 1996, IARC Technical Report No. 29: Lyon, 1996., rather than the site of tumor. Hong Kong Cancer Registry, Hospital Authority. Last updated: Nov 2017 5